TalkMed Group Limited (SGX:5G3)
0.4450
+0.0050 (1.14%)
At close: May 13, 2025, 5:00 PM SGT
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
---|---|---|---|---|---|
Oncology | 81.03M |
Log In |
Log In |
Log In |
Log In |
Oncology Growth | 10.45% |
Log In |
Log In |
Log In |
Log In |
Cellular and Gene Therapy | 2.76M |
Log In |
Log In |
Log In |
Log In |
Cellular and Gene Therapy Growth | -14.70% |
Log In |
Log In |
Log In |
Log In |
Stem Cell Related Products | - |
Log In |
Log In |
Log In |
Log In |
Stem Cell Related Products Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
---|---|---|---|---|---|
Singapore | 78.80M |
Log In |
Log In |
Log In |
Log In |
Singapore Growth | 8.69% |
Log In |
Log In |
Log In |
Log In |
China and Hong Kong | 2.16M |
Log In |
Log In |
Log In |
Log In |
China and Hong Kong Growth | 171.41% |
Log In |
Log In |
Log In |
Log In |
Australia | 1.20M |
Log In |
Log In |
Log In |
Log In |
Australia Growth | -53.18% |
Log In |
Log In |
Log In |
Log In |
New Zealand | 1.01M |
Log In |
Log In |
Log In |
Log In |
United States | 549.00K |
Log In |
Log In |
Log In |
Log In |
United States Growth | 113.62% |
Log In |
Log In |
Log In |
Log In |
Vietnam | 82.00K |
Log In |
Log In |
Log In |
Log In |
Vietnam Growth | 15.49% |
Log In |
Log In |
Log In |
Log In |
India | - |
Log In |
Log In |
Log In |
Log In |
Malaysia | - |
Log In |
Log In |
Log In |
Log In |
Malaysia Growth | - |
Log In |
Log In |
Log In |
Log In |
Indonesia | - |
Log In |
Log In |
Log In |
Log In |
Indonesia Growth | - |
Log In |
Log In |
Log In |
Log In |